BARRETT & COMPANY, INC. - EAGLE PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
BARRETT & COMPANY, INC. ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,577
-18.9%
1000.0%0.00%0.0%
Q2 2023$1,944
-31.5%
1000.0%0.00%
-50.0%
Q1 2023$2,837
-2.9%
1000.0%0.00%0.0%
Q4 2022$2,9230.0%1000.0%0.00%0.0%
Q3 2022$2,9231000.00%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Park West Asset Management LLC 1,120,235$53,749,0002.66%
TANG CAPITAL MANAGEMENT LLC 255,616$12,264,0001.19%
Smith, Graham & Co., Investment Advisors, LP 158,671$7,613,0000.92%
ARMISTICE CAPITAL, LLC 282,000$13,530,0000.59%
Capital Impact Advisors, LLC 35,815$1,718,0000.57%
Matarin Capital Management, LLC 58,977$2,830,0000.56%
GLOBEFLEX CAPITAL L P 31,702$1,521,0000.39%
CHARTWELL INVESTMENT PARTNERS, LLC 200,246$9,608,0000.37%
Stanley-Laman Group, Ltd. 24,000$1,152,0000.28%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 264$13,0000.20%
View complete list of EAGLE PHARMACEUTICALS INC shareholders